Production of multiply deleted adenoviral (Ad) vectors with increased cloning capacity and reduced immunogenicity to adenovirus gene products requires the concomitant generation of efficient packaging cell lines. High expression levels of the complementing genes must be achieved in a coordinated fashion with viral replication. This is a particularly difficult task in light of the significant cytotoxicity displayed by adenoviral proteins. To this end, we developed a novel adenovirus-based amplicon with an Epstein-Barr virus origin of replication, Ad type 5 (Ad5) inverted terminal repeats, all Ad5 early region 2 (E2) genes, and the early region 4 (E4) open reading frame 6 (ORF6) under the control of a tetracycline-dependent promoter. The ampl...
Abstract The construction of expression vectors derived from the human adenovirus type 5 (Ad5), usua...
Replication-deficient human adenovirus type 5 (Ad5) can be produced to high titers in complementing ...
Until recently, adenovirus (Ad)-mediated gene therapy was almost exclusively based on human Ad type ...
Production of multiply deleted adenoviral (Ad) vectors with increased cloning capacity and reduced i...
cell that expresses adenovirus E1 gene; Ad, adenovirus; m.u., map unit; m.o.i, multiplicity of infec...
Abstract Background Adenovirus serotype 5 (Ad5) has many favourable characteristics for development ...
With the enhanced capacity of bioinformatics to interrogate extensive banks of sequence data, more e...
We have constructed a recombinant adenovirus gene delivery system that is capable of undergoing grow...
Recombinant human adenovirus (Ad) vectors are being extensively explored for their use in gene thera...
E1-deleted adenovirus vectors (AdV) are important gene transfer vehicles for gene therapy and vaccin...
AbstractAdenoviral vectors have been used in gene therapy and for vaccination. The major concerns wi...
Genetically modified adenoviruses (Ads) make attractive vectors for the delivery of exogenous DNA to...
<div><p>The adenoviruses are essential tools for basic research and therapeutic development. Robust ...
AbstractProduction of E1-deleted adenovirus (rAd) vectors requires complementation by E1A and E1B fu...
The adenoviruses are essential tools for basic research and therapeutic development. Robust methods ...
Abstract The construction of expression vectors derived from the human adenovirus type 5 (Ad5), usua...
Replication-deficient human adenovirus type 5 (Ad5) can be produced to high titers in complementing ...
Until recently, adenovirus (Ad)-mediated gene therapy was almost exclusively based on human Ad type ...
Production of multiply deleted adenoviral (Ad) vectors with increased cloning capacity and reduced i...
cell that expresses adenovirus E1 gene; Ad, adenovirus; m.u., map unit; m.o.i, multiplicity of infec...
Abstract Background Adenovirus serotype 5 (Ad5) has many favourable characteristics for development ...
With the enhanced capacity of bioinformatics to interrogate extensive banks of sequence data, more e...
We have constructed a recombinant adenovirus gene delivery system that is capable of undergoing grow...
Recombinant human adenovirus (Ad) vectors are being extensively explored for their use in gene thera...
E1-deleted adenovirus vectors (AdV) are important gene transfer vehicles for gene therapy and vaccin...
AbstractAdenoviral vectors have been used in gene therapy and for vaccination. The major concerns wi...
Genetically modified adenoviruses (Ads) make attractive vectors for the delivery of exogenous DNA to...
<div><p>The adenoviruses are essential tools for basic research and therapeutic development. Robust ...
AbstractProduction of E1-deleted adenovirus (rAd) vectors requires complementation by E1A and E1B fu...
The adenoviruses are essential tools for basic research and therapeutic development. Robust methods ...
Abstract The construction of expression vectors derived from the human adenovirus type 5 (Ad5), usua...
Replication-deficient human adenovirus type 5 (Ad5) can be produced to high titers in complementing ...
Until recently, adenovirus (Ad)-mediated gene therapy was almost exclusively based on human Ad type ...